Hepatomegaly and Splenomegaly Evaluation

Metabolic Storage Disorders

Glycogen storage diseases (GSDs) frequently present with hepatomegaly, with some types also causing splenomegaly 1, 2
Lysosomal storage diseases commonly present with both hepatomegaly and splenomegaly, with Niemann-Pick disease showing significant hepatosplenomegaly, growth failure, hyperlipidemia, and characteristic storage cells 1, 3
Acid sphingomyelinase deficiency (ASMD) can present with massive splenomegaly (>10x normal size) 4, 5
Lysosomal acid lipase deficiency (LALD) presents with hepatosplenomegaly and dyslipidemia 3, 5

Wilson disease can present with isolated splenomegaly due to clinically inapparent cirrhosis with portal hypertension, and may also show Kayser-Fleischer rings, neurological or psychiatric symptoms 6, 3
Cirrhosis with portal hypertension is a common cause of splenomegaly, often associated with thrombocytopenia and other signs of portal hypertension 3
Cystic fibrosis hepatobiliary involvement can present with hepatosplenomegaly, and annual screening with labs and physical examination is recommended 7, 5

Myeloproliferative disorders, particularly myelofibrosis, are associated with massive splenomegaly 4
Autoimmune disorders, including rheumatoid arthritis with Felty syndrome, can cause splenomegaly 3

Initial laboratory evaluation should include complete blood count, liver function tests, lipid profile, blood glucose, lactate, and uric acid levels 5, 7, 8, 1
Imaging studies, such as abdominal ultrasound, liver elastography, and chest X-ray or CT, can help confirm hepatosplenomegaly and assess for other abdominal pathology 7, 5
Specialized testing, including genetic testing and enzymatic analysis on liver biopsy samples, may be necessary based on clinical suspicion 5, 1, 2

Patients with hepatosplenomegaly should be initially referred to a hepatologist or gastroenterologist, as the liver is often the primary affected organ in most cases of hepatosplenomegaly 9
The liver is often the primary affected organ in conditions causing hepatosplenomegaly, with fibrosis and development of cirrhosis being major morbidities 9
Transaminases are often increased early in the disease course of conditions causing hepatosplenomegaly, further supporting initial hepatology referral 9

Liver function tests should be performed to evaluate hepatocellular injury and cholestasis, including transaminases, gamma-glutamyl transferase, and alkaline phosphatase 10
Lipid profile should be assessed, as mixed dyslipidemia is common in storage disorders 9

In patients with known bleeding disorders who develop hepatosplenomegaly, a joint evaluation by both a hepatologist and hematologist is recommended 10
For pediatric patients with hepatosplenomegaly, referral to a pediatric gastroenterologist/hepatologist is appropriate, with subsequent referral to a metabolic specialist if storage disorders are suspected 11
In cases of massive splenomegaly, both hepatology and hematology consultation may be needed concurrently 9

Delaying referral to a hepatologist when hepatosplenomegaly is identified can prevent progression of liver fibrosis and should be avoided 9, 10

In children aged 1-3 years, hepatosplenomegaly is identified by measuring the spleen size below the costal margin during physical examination, with the spleen being palpable in approximately 12% of healthy children in this age group, making careful technique and age-appropriate reference values essential 12
Measure and document the distance (in centimeters) that the spleen extends below the left costal margin during deep inspiration with the child in supine position 13
The spleen may be palpable in up to 12% of normal children, particularly infants, so palpability alone does not confirm pathologic splenomegaly 12
Children with pathologic conditions present with larger spleen sizes compared to adults with similar conditions 13
Measure the liver span by percussion and palpation, documenting how far the liver edge extends below the right costal margin in the midclavicular line 13

Do not rely solely on palpability—up to 12% of healthy children have palpable spleens, and ultrasound with age-appropriate reference values is required for definitive diagnosis 12